Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"APAP Selection"”.

  1. Ex Vivo Multiplex Knockdown of ANGPTL3 and Cypor in Hepatocytes as a Novel Cell Therapy for Familial Hypercholesterolemia

    … (CYPOR), followed by treatment with APAP, can potentially increase engraftment by gene-edited cells in the liver after transplantation. Our cell-based gene-editing strategy for treating FH involves isolating hepatocytes from the patient, editing hepatocytes ex vivo with CRISPR-Cas to …

    clemson Repository record for Ex Vivo Multiplex Knockdown of ANGPTL3 and Cypor in Hepatocytes as a Novel Cell Therapy for Familial Hypercholesterolemia (opens in a new tab)

  2. Optimizing CRISPR/Cas9-mediated knockdown of ANGPTL3 in liver cell lines and mouse hepatocytes

    … for cells that have been edited. Acetaminophen (APAP) selection is a novel method to overcome this barrier that combines the delivery of therapeutic transgenes with the knockdown of the CYPOR gene that produces toxic metabolites to provide a selective advantage to edited cells (Vonada et al., …

    clemson Repository record for Optimizing CRISPR/Cas9-mediated knockdown of ANGPTL3 in liver cell lines and mouse hepatocytes (opens in a new tab)

  3. Multiplex Gene Editing in Hepatocytes as a Therapeutic Approach for Familial Hypercholesterolemia

    … advantage over native cells. Acetaminophen (APAP) selection is a novel method that can be used to provide this selective advantage for edited cells to repopulate the liver. Knockdown of ANGPTL3 along with NADPH-cytochrome p450 reductase (CYPOR), followed by transient APAP administration can …

    clemson Repository record for Multiplex Gene Editing in Hepatocytes as a Therapeutic Approach for Familial Hypercholesterolemia (opens in a new tab)